Yatharth Hospital

Yatharth Hospital

810.70
-5.10
(-0.63%)
hide
Key Fundamentals
Add Ratio
Market Cap
7,860.60 Cr
EPS
14.72
PE Ratio
54.91
Dividend Yield
0.00 %
52 Week High
843.70
52 Week Low
345.60
PB Ratio
4.86
Debt to Equity
0.04
Sector
Hospitals
Analyst Rating and Forecast
- By Refinitiv from1 analysts
SELL
Analysts have suggested that investors can sell this stock
Buy
Buy0.0 %
0.0 %
Hold
Hold0.0 %
0.0 %
Sell
Sell+100.00 %
+100.00 %
Forecast For
Actual

Company News

View All News
Caret
positive
Kedia Securities Private Limited has acquired a 1% stake in Yatharth Hospital during the second quarter. The acquisition represents an investment by the securities firm in the healthcare company.
positive
Yatharth Hospital & Trauma Care Services shares surged over 10% to reach an all-time high of ₹839, following the Union Health Ministry's announcement of revised rates for nearly 2,000 medical procedures under the Central Government Health Services (CGHS) scheme. The new multi-layered rate structure, effective October 13, provides different compensation based on hospital accreditation and type - with super-specialty hospitals with over 200 beds earning 15% above base rates, while non-accredited facilities receive 15% lower rates. CGHS covers 4.6 million beneficiaries across 80 cities and last underwent major rate revisions in 2014. Yatharth Hospital reported strong financial performance with net profit jumping 40% to ₹42 crore and revenue rising 22% to ₹258 crore. The stock has gained over 55% in the past year, trading above all major moving averages.
positive
Yatharth Hospital and Trauma Care Services Limited's board approved the acquisition of 100% interest in Shantived Institute of Medical Sciences for an enterprise value of Rs. 260 crores. The target hospital is a 150-bed super specialty facility in Agra, Uttar Pradesh, expandable to 250 beds and spread across 1,65,000 square feet. The acquisition will be completed through cash consideration within 3 months and aims to expand Yatharth's presence and strengthen its positioning in the healthcare sector. The transaction is not a related party deal and requires no government or regulatory approvals.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,202.70
#1 1,14,266.90
101.89
7,184.10
#1 28.68
1,076
30.34
60.77
7,901.50
1,12,633.70
69.74
#1 21,994.30
14.76
#1 1,505
39.78
64.47
1,084.90
82,686.80
90.81
7,849.70
13.25
809
#1 53.33
68.38
1,371.70
37,523.10
69.05
3,771.40
12.59
481
49.58
53.54
702.45
36,234.80
104.27
4,286.70
15.12
337
-98.18
65.62
1,755.40
36,063.60
#1 45.68
5,575.00
12.29
790
-2.38
47.19
719.90
29,362.20
71.28
3,067.00
21.98
415
-10.71
49.37
1,348.80
13,375.30
53.04
1,566.90
17.46
244
35.52
41.78
1,544.00
10,034.20
52.47
1,290.20
17.77
194
-1.57
59.98
733.55
10,001.10
250.98
2,257.70
17.03
49
-55.88
71.60

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
30.68 %
Net Income Growth
13.97 %
Cash Flow Change
4,957.14 %
ROE
-39.11 %
ROCE
-37.63 %
EBITDA Margin (Avg.)
-7.47 %

Quarterly Financial Results

Quarterly Financials
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
112
129
138
145
155
175
172
183
215
221
223
237
267
Expenses
85
94
102
105
113
126
120
131
158
163
164
175
193
EBITDA
26
34
37
39
42
49
52
52
57
58
59
62
74
Operating Profit %
23 %
26 %
26 %
27 %
27 %
27 %
28 %
26 %
25 %
25 %
25 %
25 %
25 %
Depreciation
6
6
7
8
7
7
8
8
11
16
17
13
15
Interest
5
5
6
6
6
3
0
0
3
2
2
1
0
Profit Before Tax
16
23
24
25
29
40
44
44
43
40
40
49
59
Tax
5
7
3
8
10
12
14
6
13
9
10
10
17
Net Profit
11
16
21
17
19
28
30
38
30
31
31
39
42
EPS in ₹
1.67
2.48
3.04
2.64
2.91
3.80
3.83
4.85
3.54
3.59
3.57
4.37
4.36

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
193
257
287
309
426
486
1,019
1,731
Fixed Assets
54
164
190
251
303
299
442
605
Current Assets
28
24
29
49
109
176
510
856
Capital Work in Progress
110
65
62
0
0
0
0
222
Investments
0
0
0
0
0
0
0
75
Other Assets
30
28
36
58
123
187
578
830
Total Liabilities
193
257
287
309
426
486
1,019
1,731
Current Liabilities
10
42
60
55
97
100
67
85
Non Current Liabilities
126
156
165
173
212
204
78
10
Total Equity
57
58
62
81
117
183
874
1,637
Reserve & Surplus
41
39
38
56
51
117
789
1,509
Share Capital
16
16
16
16
66
66
86
96

Cash Flow

Cash Flow
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
9
-13
1
3
7
26
75
249
Investing Activities
-50
-51
-78
-43
-21
-52
-20
-226
-420
Operating Activities
25
17
18
39
44
60
64
-3
150
Financing Activities
26
43
47
5
-19
-1
-18
304
520

Share Holding

% Holding
Mar 2022
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
96.91 %
66.33 %
66.33 %
66.33 %
66.44 %
66.54 %
66.54 %
66.54 %
61.44 %
61.64 %
61.64 %
61.64 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.99 %
4.89 %
6.28 %
9.78 %
4.45 %
4.34 %
6.50 %
DIIs
0.00 %
9.07 %
6.74 %
8.88 %
8.81 %
9.33 %
9.41 %
6.98 %
11.50 %
13.56 %
13.52 %
8.70 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
16.00 %
16.00 %
10.12 %
12.82 %
11.98 %
12.11 %
14.19 %
11.83 %
14.87 %
15.29 %
17.28 %
Others
3.09 %
8.59 %
10.93 %
14.67 %
11.92 %
8.15 %
7.04 %
6.01 %
5.45 %
5.48 %
5.21 %
5.88 %
No of Share Holders
7
1,65,190
1,65,190
50,113
51,743
46,567
51,916
62,616
73,251
85,668
81,440
91,434

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Sept 2024 583.75 572.90
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 659.05 668.20
06 Dec 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
06 Dec 2024 584.70 618.70
27 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Jan 2025 438.45 442.90
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2025 506.70 523.00
05 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Aug 2025 627.80 650.80
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 749.65 750.00

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20189 days ago
Appointment Of The Statutory Auditor And Secretarial Auditor Of The CompanySep 30, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Voting Results Of The 18Th Annual General MeetingSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Closure of Trading WindowSep 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 13, 2025
Announcement under Regulation 30 (LODR)-AcquisitionSep 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 09, 2025
Business Responsibility and Sustainability Reporting (BRSR)Sep 08, 2025
Reg. 34 (1) Annual Report.Sep 08, 2025
Notice Of 18Th Annual General Meeting Of The CompanySep 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesSep 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 19, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 12, 2025
Monitoring Agency Report For The Quarter Ended June 30 2025 - IPOAug 12, 2025
Monitoring Agency Report For The Quarter Ended June 30 2025 - QIP.Aug 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 05, 2025
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 05, 2025
Appointment Of Secretarial Auditor & Cost AuditorAug 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 05, 2025
Un-Audited Financial Results For The Quarter Ended June 30 2025.Aug 05, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. August 05 2025Aug 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 01, 2025
Board Meeting Intimation for Unaudited Financial Results For The First Quarter FY26Jul 31, 2025
Announcement under Regulation 30 (LODR)-Change in Corporate Office AddressJul 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Announcement Under Reg. 30 Part A Para B.Jul 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 03, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 03, 2025
Resolution Of Ramraja Hospital Land DisputeJun 30, 2025
Closure of Trading WindowJun 28, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 04, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2025
Re-Appointment Of M/S Deloitte Touche Tohmatsu India LLP As Internal Auditor For The FY 2025-26.May 27, 2025
Resignation Of Mr. Neeraj VinayakMay 27, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 26, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 26, 2025
Audited Financial Results For The Q4 & FY25May 26, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 26, 2025
Board Meeting Outcome for Audited Financial Result For Q4 & FY2025May 26, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.24%
-458726
-0.50%
-0.98%
Bandhan Small Cap Fund Direct-Growth
1.26%
-217716
-0.12%
-0.20%
Kotak Balanced Advantage Fund Direct - Growth
0.58%
-107270
-0.01%
0.01%
Taurus Mid Cap Fund Direct - Growth
0.61%
-22951
-1.21%
-1.89%
Groww Multicap Fund Direct-Growth
0.56%
-21726
-1.00%
-1.11%
Groww Value Fund Direct-Growth
0.00%
-17556
-2.02%
-1.90%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.36%
-1845
0.01%
0.05%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.21%
-15
0.02%
0.03%
Groww Nifty Total Market Index Fund Direct - Growth
0.01%
-4
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.01%
-2
0.00%
0.00%
Angel One Nifty Total Market Index Fund Direct - Growth
0.01%
1
0.00%
0.00%
Bandhan Aggressive Hybrid Fund Direct-Growth
0.00%
0
0.00%
0.00%
Kotak Multicap Fund Direct - Growth
0.86%
0
0.01%
0.06%
HDFC Non-Cyclical Consumer Fund Direct - Growth
0.00%
0
0.00%
0.00%
Groww Large Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
ITI Pharma and Healthcare Fund Direct - Growth
0.00%
0
0.00%
0.00%
Groww ELSS Tax Saver Fund Direct - Growth
0.00%
0
0.00%
0.00%
Kotak Healthcare Fund Direct - Growth
1.44%
0
0.10%
-0.02%
Bandhan Innovation Fund Direct-Growth
0.00%
0
0.00%
0.00%
LIC MF Healthcare Fund Direct - Growth
0.00%
0
0.00%
0.00%
LIC MF Infrastructure Fund Direct-Growth
0.00%
0
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.00%
Groww Aggressive Hybrid Fund Direct - Growth
0.00%
0
0.00%
0.00%
Taurus Flexi Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
Bajaj Finserv Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
58.56
ATR(14)
Less Volatile
28.40
STOCH(9,6)
Neutral
69.41
STOCH RSI(14)
Neutral
70.70
MACD(12,26)
Bullish
0.91
ADX(14)
Strong Trend
26.50
UO(9)
Bearish
37.44
ROC(12)
Uptrend And Accelerating
9.38
WillR(14)
Neutral
-29.88